文献速递重症综合管理与镇静镇痛

性别差异与小鼠外科脓毒症后晚期微生物组改变相关

Sex differences associate with late microbiome alterations after murine surgical sepsis.
PubMed 文献 · J Trauma Acute Care Surg · 2022-03-24
一句话结论小鼠CLP脓毒症后雄性菌群α多样性持续降低至14天,雌性7天降低但14天恢复,恢复主要见于年轻雌鼠。

该研究对混合性别C57BL/6小鼠行盲肠结扎穿刺(CLP)并给予抗生素、生理盐水复苏和每日慢性应激,与未脓毒症/未用抗生素的对照比较,按性别分析年轻(3-5月龄)和老年(18-22月龄)成年小鼠第7天和第14天粪便16S rRNA基因测序。对照雌雄小鼠α和β多样性无差异(FDR分别为0.76和0.99);雄性CLP后第7天α多样性降低(Shannon FDR 0.005)并持续至第14天(FDR 0.001),β多样性至第14天仍与对照不同(FDR<0.0001);雌性第7天α(FDR 0.03)和β多样性(FDR 0.02)降低,但第14天恢复(Shannon FDR 0.5,FDR 0.02),且仅年轻雌鼠第14天β多样性与对照无差异。作者认为这种恢复差异可能参与脓毒症后性别间结局差异。

要点

  • 雄性小鼠CLP后第7天肠道菌群α多样性降低(Shannon FDR 0.005),第14天仍持续降低(FDR 0.001),β多样性至第14天仍与对照不同(FDR<0.0001)。
  • 雌性小鼠CLP后第7天α多样性(Shannon FDR 0.03)和β多样性(FDR 0.02)降低,但第14天α多样性恢复至与对照无差异(Shannon FDR 0.5)。
  • 进一步分析显示仅年轻雌鼠CLP后第14天β多样性与对照无差异,提示恢复主要见于年轻雌性。
  • 对照雌雄小鼠α和β多样性无差异(FDR分别为0.76和0.99),性别差异出现在脓毒症后而非基线。
  • 作者认为脓毒症后菌群恢复的性别差异可能参与两性结局差异。

适用人群与场景

  • 混合性别C57BL/6小鼠,包括年轻(3-5个月)和老年(18-22个月)成年小鼠,行CLP并给予抗生素、生理盐水复苏和每日慢性应激,与未脓毒症/未用抗生素的对照比较。

研究设计与关键结果

  • 研究类型为动物实验,对混合性别C57BL/6小鼠行盲肠结扎穿刺(CLP)并给予抗生素、生理盐水复苏和每日慢性应激,与未脓毒症/未用抗生素的对照比较,按性别分析年轻(3-5个月)和老年(18-22个月)成年小鼠,第7天和第14天处死行粪便16S rRNA基因测序,α和β多样性分别用Shannon指数和Bray-Curtis主坐标分析,采用FDR校正 housing 效应。
  • 对照雌雄小鼠α和β多样性无差异(FDR分别为0.76和0.99)。
  • 雄性CLP后第7天α多样性较基线降低(Shannon FDR 0.005),第14天持续降低(Shannon FDR 0.001);β多样性至第14天仍与对照不同(FDR<0.0001)。
  • 雌性CLP后第7天α多样性降低(Shannon FDR 0.03)、β多样性降低(FDR 0.02),但第14天α多样性恢复(Shannon FDR 0.5)、β多样性恢复(FDR 0.02)。
  • 进一步分析雌性显示仅年轻雌鼠CLP后第14天β多样性与对照无差异。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为脓毒症后菌群恢复的性别差异可能参与两性结局差异;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis-induced gut microbiome alterations contribute to sepsis-related morbidity and mortality. Given evidence for improved postsepsis outcomes in females compared with males, we hypothesized that female mice maintain microbiota resilience versus males.

METHODS: Mixed-sex C57BL/6 mice underwent cecal ligation and puncture (CLP) with antibiotics, saline resuscitation, and daily chronic stress and were compared with naive (nonsepsis/no antibiotics) controls. For this work, the results of young (3-5 months) and old (18-22 months) adult mice were analyzed by sex, independent and dependent of age. Mice were sacrificed at days 7 and 14, and 16S rRNA gene sequencing was performed on fecal bacterial DNA. α and β diversity were determined by Shannon index and Bray-Curtis with principal coordinate analysis, respectively. False discovery rate (FDR) correction was implemented to account for potential housing effect.

RESULTS: In control mice, there was no difference in α or β diversity between male and female mice (FDR, 0.76 and 0.99, respectively). However, male mice that underwent CLP with daily chronic stress had a decrease in microbiota α diversity at 7 days post-CLP (Shannon FDR, 0.005), which was sustained at 14 days post-CLP (Shannon FDR, 0.001), compared with baseline. In addition, male mice maintained differences in β diversity even at day 14 compared with controls (FDR, <0.0001). In contrast, female mice had a decreased microbiota α diversity (Shannon FDR, 0.03) and β diversity (FDR, 0.02) 7 days post-CLP but recovered their α and β diversity by post-CLP day 14 (Shannon FDR, 0.5, and FDR, 0.02, respectively). Further analysis of females revealed that only young female mice were not different (β diversity) post-CLP day 14 to controls.

CONCLUSION: Although sepsis-induced perturbations of the intestinal microbiota occur initially in both male and female C57BL/6 mice, females demonstrate different microbiota by day 14. This may be seen primarily in younger females. This difference in recovery may play a role in outcome differences between sexes after sepsis.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Efron PA, Darden DB, Li EC, et al. Sex differences associate with late microbiome alterations after murine surgical sepsis. J Trauma Acute Care Surg. 2022. PMID: 35324554. doi:10.1097/TA.0000000000003599

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。